138 related articles for article (PubMed ID: 34853164)
1. Prognostic significance of tumour budding, tumour-stroma ratio and desmoplastic stromal reaction in gall bladder carcinoma.
Goyal S; Banga P; Meena N; Chauhan G; Sakhuja P; Agarwal AK
J Clin Pathol; 2023 May; 76(5):308-314. PubMed ID: 34853164
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of the tumor-stroma ratio in gallbladder cancer.
Li H; Yuan SL; Han ZZ; Huang J; Cui L; Jiang CQ; Zhang Y
Neoplasma; 2017; 64(4):588-593. PubMed ID: 28485165
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of tumour-stroma ratio in endometrial carcinoma.
Panayiotou H; Orsi NM; Thygesen HH; Wright AI; Winder M; Hutson R; Cummings M
BMC Cancer; 2015 Dec; 15():955. PubMed ID: 26674153
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of desmoplastic stromal reaction, tumor budding and tumor-stroma ratio in stage II colorectal cancer.
Fan S; Cui X; Zheng L; Ma W; Zheng S; Wang J; Qi L; Ye Z
J Gastrointest Oncol; 2022 Dec; 13(6):2903-2921. PubMed ID: 36636094
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of tumour-stroma ratio in early-stage oral tongue cancers.
Almangush A; Heikkinen I; Bakhti N; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Soini Y; Kowalski LP; Grénman R; Haglund C; Mäkitie AA; Coletta RD; Leivo I; Salo T
Histopathology; 2018 Jun; 72(7):1128-1135. PubMed ID: 29427291
[TBL] [Abstract][Full Text] [Related]
6. Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study.
Smit MA; van Pelt GW; Terpstra V; Putter H; Tollenaar RAEM; Mesker WE; van Krieken JHJM
Int J Colorectal Dis; 2021 Dec; 36(12):2729-2737. PubMed ID: 34533595
[TBL] [Abstract][Full Text] [Related]
7. Prognostication for oral squamous cell carcinoma patients based on the tumour-stroma ratio and tumour budding.
Dourado MR; Miwa KYM; Hamada GB; Paranaíba LMR; Sawazaki-Calone Í; Domingueti CB; Ervolino de Oliveira C; Furlan ECB; Longo BC; Almangush A; Salo T; Coletta RD
Histopathology; 2020 May; 76(6):906-918. PubMed ID: 31984527
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Significance of Tumour Budding and Desmoplastic Reaction in Intestinal-Type Gastric Adenocarcinoma.
Pun C; Luu S; Swallow C; Kirsch R; Conner JR
Int J Surg Pathol; 2023 Sep; 31(6):957-966. PubMed ID: 35726174
[No Abstract] [Full Text] [Related]
9. The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study.
Eriksen AC; Sørensen FB; Lindebjerg J; Hager H; dePont Christensen R; Kjær-Frifeldt S; Hansen TF
Int J Colorectal Dis; 2018 Aug; 33(8):1115-1124. PubMed ID: 29785462
[TBL] [Abstract][Full Text] [Related]
10. Results from the UNITED study: a multicenter study validating the prognostic effect of the tumor-stroma ratio in colon cancer.
Polack M; Smit MA; van Pelt GW; Roodvoets AGH; Meershoek-Klein Kranenbarg E; Putter H; Gelderblom H; Crobach ASLP; Terpstra V; Petrushevska G; Gašljević G; Kjær-Frifeldt S; de Cuba EMV; Bulkmans NWJ; Vink GR; Al Dieri R; Tollenaar RAEM; van Krieken JHJM; Mesker WE;
ESMO Open; 2024 Apr; 9(4):102988. PubMed ID: 38613913
[TBL] [Abstract][Full Text] [Related]
11. Tumour Budding and Tumour Stroma Ratio are Reliable Predictors for Death and Recurrence in Elderly Stage I Colon Cancer Patients.
Zengin M
Pathol Res Pract; 2019 Nov; 215(11):152635. PubMed ID: 31564570
[TBL] [Abstract][Full Text] [Related]
12. Histological categorisation of fibrotic cancer stroma in advanced rectal cancer.
Ueno H; Jones AM; Wilkinson KH; Jass JR; Talbot IC
Gut; 2004 Apr; 53(4):581-6. PubMed ID: 15016755
[TBL] [Abstract][Full Text] [Related]
13. Association between tumor-stroma ratio and prognosis in solid tumor patients: a systematic review and meta-analysis.
Wu J; Liang C; Chen M; Su W
Oncotarget; 2016 Oct; 7(42):68954-68965. PubMed ID: 27661111
[TBL] [Abstract][Full Text] [Related]
14. A high tumour-stroma ratio (TSR) in colon tumours and its metastatic lymph nodes predicts poor cancer-free survival and chemo resistance.
Strous MTA; Faes TKE; Gubbels ALHM; van der Linden RLA; Mesker WE; Bosscha K; Bronkhorst CM; Janssen-Heijnen MLG; Vogelaar FJ; de Bruïne AP
Clin Transl Oncol; 2022 Jun; 24(6):1047-1058. PubMed ID: 35064453
[TBL] [Abstract][Full Text] [Related]
15. Standardized Assessment of the Tumor-Stroma Ratio in Colorectal Cancer: Interobserver Validation and Reproducibility of a Potential Prognostic Factor.
Souza da Silva RM; Queiroga EM; Paz AR; Neves FFP; Cunha KS; Dias EP
Clin Pathol; 2021; 14():2632010X21989686. PubMed ID: 33634262
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of tumor budding in gallbladder cancer: application of the International Tumor Budding Consensus Conference scoring system.
Kim HN; Lee SY; Kim BH; Kim CY; Kim A; Kim H
Virchows Arch; 2021 Jun; 478(6):1071-1078. PubMed ID: 33398430
[TBL] [Abstract][Full Text] [Related]
17. Tumour budding and tumour-stroma ratio in hepatocellular carcinoma.
Kairaluoma V; Kemi N; Pohjanen VM; Saarnio J; Helminen O
Br J Cancer; 2020 Jul; 123(1):38-45. PubMed ID: 32362654
[TBL] [Abstract][Full Text] [Related]
18. The tumor-stroma ratio is an independent predictor of survival in patients with 2018 FIGO stage IIIC squamous cell carcinoma of the cervix following primary radical surgery.
Zong L; Zhang Q; Kong Y; Yang F; Zhou Y; Yu S; Wu M; Chen J; Zhang Y; Xiang Y
Gynecol Oncol; 2020 Mar; 156(3):676-681. PubMed ID: 31882242
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of low CDX2 expression in colorectal cancers with a high stromal content - a short report.
Sandberg TP; Sweere I; van Pelt GW; Putter H; Vermeulen L; Kuppen PJ; Tollenaar RAEM; Mesker WE
Cell Oncol (Dordr); 2019 Jun; 42(3):397-403. PubMed ID: 30847807
[TBL] [Abstract][Full Text] [Related]
20. Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer?
Eriksen AC; Andersen JB; Lindebjerg J; dePont Christensen R; Hansen TF; Kjær-Frifeldt S; Sørensen FB
Diagn Pathol; 2018 Mar; 13(1):20. PubMed ID: 29558947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
